404
Proton Pump Inhibitors (PPIs) Market Report
Global Proton Pump Inhibitors (PPIs) Market, Trends, Market Analysis
Global Proton Pump Inhibitors (PPIs) Market report is segmented By Drug Type (Over-the-counter Drugs [Omeprazole, Lansoprazole, Esomeprazole, Others], Prescription Drugs [Rabeprazole, Dexlansoprazole, Pantoprazole, Others]), By Disease (Ulcers, Gastroesophageal Reflux Disease, Others), By Distribution Channel (...
The proton pump inhibitors market is expected to witness an impressive growth of 4.7% CAGR in the foreseeable future.
AstraZeneca PLC/AB (UK), Bayer AG (Germany), Pfizer Inc. (The U.S), Cadila Pharmaceuticals Limited (India), Eisai Pharmaceuticals India Pvt. Ltd (India), Santarus, Inc. (The U.S), Wyeth, LLC (The U.S), Janssen Pharmaceutical (Belgium), Takeda Pharmaceutical Company Limited (Japan) and Sanofi S.A. (France) are among the key players in the proton pump inhibitors market.
The proton pump inhibitors market size is expected to reach USD 3.76 billion in the coming years.
North America accounted for the largest share of proton pump inhibitors market in 2020.
The esomeprazole under the OTC drug segment garnered the highest share in the proton pump inhibitors market.
Growing acceptance of novel drug delivery systems and increasing prevalence of peptic ulcers and other gastrointestinal disorders are the factors driving the growth of proton pump inhibitors market.
Proton Pump Inhibitors (PPIs) companies, Proton Pump Inhibitors (PPIs) vendors, Hospitals, Pharmaceutical companies, R&D organizations are the target audience in the proton pump inhibitors market.